Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  International Journal of Cardiology

• Publication date

  2008-11-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijcard.2008.05.036PMID 18667247
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the rigenera study).

  2007cited by this paper
• Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment.

  2007cited by this paper
• Mobilization of CD34(+), CD117(+), CXCR4(+), c-met(+) stem cells is correlated with left ventricular ejection fraction and plasma NT-proBNP levels in patients with acute myocardial infarction.

  2006cited by this paper
• Safety of granulocyte-colony-stimulating factor in acute myocardial infarction (the Rigenera study)

  2006cited by this paper
• Comparative Analysis of Methods for Assessment of Circulating Endothelial Progenitor Cells

  2006cited by this paper
• Review: Endothelial Cells Cultured on Engineered Vascular Grafts Are Able to Transduce Shear Stress

  2006cited by this paper
• Mobilization of Bone Marrow-Derived Stem Cells (BMSC) After Myocardial Infarction and Left Ventricular Function

  2005cited by this paper
• Circulating endothelial progenitor cells and cardiovascular outcomes.

  2005cited by this paper
• Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function.

  2005cited by this paper
• Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells.

  2005cited by this paper
• National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section

  2004cited by this paper
• Intensive versus moderate lipid lowering with statins after acute coronary syndromes.

  2004cited by this paper
• Statin therapy in patients with coronary artery disease improves the impaired endothelial progenitor cell differentiation into cardiomyogenic cells

  2003cited by this paper
• Transdifferentiation of Blood-Derived Human Adult Endothelial Progenitor Cells Into Functionally Active Cardiomyocytes

  2003cited by this paper
• HMG-CoA Reductase Inhibitors Reduce Senescence and Increase Proliferation of Endothelial Progenitor Cells via Regulation of Cell Cycle Regulatory Genes

  2003cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

  2002cited by this paper
• Increase in Circulating Endothelial Progenitor Cells by Statin Therapy in Patients With Stable Coronary Artery Disease

  2001influential reference
• Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study.

  2001cited by this paper
• HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway.

  2001cited by this paper
• Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.

  2001influential reference
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper

• A comprehensive review of clinical trials and Progress in stem cell therapies for advanced heart failure

  2025cites this paper
• Post-myocardial Infarction Cardiac Remodeling: Multidimensional Mechanisms and Clinical Prospects of Stem Cell Therapy

  2025cites this paper
• The Role of Endothelial Progenitor Cells in Atherosclerosis and Impact of Anti-Lipemic Treatments on Endothelial Repair

  2022cites this paper
• Collateral circulation is a predictor for in-stent restenosis after cerebral anterior circulation large artery stenting

  2021cites this paper
• Progenitor Cells and Clinical Outcomes in Patients With Acute Coronary Syndromes

  2018cites this paper
• Endothelial Progenitor Cells: Properties, Function, and Response to Toxicological Stimuli

  2018cites this paper
• Endothelial dysfunction in atherosclerosis and type 2 diabetes : clinical and molecular studies of the role of endothelin and arginase

  2018cites this paper
• Efecto protector de diferentes dosis de atorvastatina en la evolución funcional y clínica de los pacientes sometidos a revascularización miocárdica

  2017cites this paper
• Endothelial progenitor cells: Exploring the pleiotropic effects of statins

  2017cites this paper
• The Beneficial Effects of Cardiac Rehabilitation on the Function and Levels of Endothelial Progenitor Cells.

  2017cites this paper
• Effects of Intensive Statin Therapy on Left Ventricular Function in Patients with Myocardial Infarction and Abnormal Glucose Tolerance

  2017cites this paper
• Impact of statin therapy intensity on endothelial progenitor cells after percutaneous coronary intervention in diabetic patients. The REMEDY-EPC late study.

  2017cites this paper
• Prognostic impact of intensive statin therapy on N‐terminal pro‐BNP level in non‐ST‐segment elevation acute myocardial infarction patients

  2017cites this paper
• Progenitor Cells for Arterial Repair: Incremental Advancements towards Therapeutic Reality

  2017cites this paper
• Statins and myocardial infarction: Type, dose, and administration time: Does it matter?

  2016cites this paper
• Endothelial progenitor cells (EPCs) in ageing and age-related diseases: How currently available treatment modalities affect EPC biology, atherosclerosis, and cardiovascular outcomes.

  2016cites this paper
• Effect of High-Dose Atorvastatin Reload on the Release of Endothelial Progenitor Cells in Patients on Long-Term Statin Treatment Who Underwent Percutaneous Coronary Intervention (from the ARMYDA-EPC Study).

  2016influential citation
• Stem Cell Therapy of Ischemic Heart Disease

  2016cites this paper
• Expert consensus on intensive statin therapy for patients with acute coronary syndrome

  2016cites this paper
• Clinical use of statins in hematopoietic stem cell transplantation: Old drugs and new horizons

  2016cites this paper
• Impact of Previous Stroke on Short-Term Myocardial Reinfarction in Patients With Acute ST Segment Elevation Myocardial Infarction

  2016cites this paper
• Favorable effect of optimal lipid-lowering therapy on neointimal tissue characteristics after drug-eluting stent implantation: qualitative optical coherence tomographic analysis.

  2015cites this paper
• Intensive Statin Therapy in NSTE-ACS Patients Undergoing PCI: Clinical and Biochemical Effects.

  2015cites this paper
• Effects of short-term pretreatment with atorvastatin on mobilization of hematopoietic progenitor cells: A double-blind, randomized, controlled trial

  2015cites this paper
• Diabetes, Endothelial Dysfunction, and Vascular Repair: What Should a Diabetologist Keep His Eye on?

  2015cites this paper
• Endoethelial Progenitor Cells are Affected by Medications and Estrogen.

  2015cites this paper
• Association between mobilization of circulating endothelial progenitor cells and time or degree of injury from angioplasty in patients with exertional angina: A prospective study.

  2015cites this paper
• Focus on biological identity of endothelial progenitors cells.

  2015cites this paper
• Modulating factors of progenitor stem cell kinetics in STEMI patients undergoing primary angioplasty - a pilot study.

  2014cites this paper
• Improving cardiovascular outcomes in rheumatic diseases: therapeutic potential of circulating endothelial progenitor cells.

  2014cites this paper
• Impact of prior chronic statin therapy and high-intensity statin therapy at discharge on circulating endothelial progenitor cell levels in patients with acute myocardial infarction: a prospective observational study

  2014cites this paper
• Statins for acute coronary syndrome.

  2014cites this paper
• Plaque regression and progenitor cell mobilization with intensive lipid elimination regimen (PREMIER) trial design

  2014cites this paper
• Impact of inorganic nitrate in cardiovascular ischemic disease

  2014cites this paper
• Cardiac cell therapy: current status and future trends

  2014cites this paper
• Endothelial progenitor cells in cardiovascular diseases.

  2014cites this paper
• Effect of atorvastatin on the angiogenic responsiveness of coronary endothelial cells in normal and streptozotocin (STZ) induced diabetic rats.

  2014cites this paper
• Circulating CD34(+) progenitor cell frequency is associated with clinical and genetic factors.

  2013cites this paper
• Endothelial progenitor cells, microvascular obstruction, and left ventricular remodeling in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention.

  2013cites this paper
• Endothelial progenitor cells in coronary artery disease

  2013cites this paper
• Increasing Doses of Simvastatin Versus Combined Ezetimibe/Simvastatin

  2013cites this paper
• Endothelial progenitor cells in relation to endothelin-1 and endothelin receptor blockade: a randomized, controlled trial.

  2013cites this paper
• The birth of ‘regenerative pharmacology’: a clinical perspective

  2013cites this paper
• Statins and stem cell modulation.

  2013cites this paper
• Medical imaging for cardiac regeneration using resident cardiac stem cells

  2013cites this paper
• Endothelial progenitor cells--potential new avenues to improve neoangiogenesis and reendothelialization.

  2013cites this paper
• The Effect of Statins on Circulating Endothelial Progenitor Cells in Humans: A Systematic Review

  2013cites this paper
• COPYRIGHT PULSUS GROUP INC. – DO NOT COPY

  2013cites this paper
• Perspectives on stem cell therapy for cardiac regeneration. Advances and challenges.

  2012cites this paper
• Regenerative Therapy Using Blood-Derived Stem Cells

  2012cites this paper
• Current Stem Cell Delivery Methods for Myocardial Repair

  2012cites this paper
• Pharmacological Actions of Statins: A Critical Appraisal in the Management of Cancer

  2012cites this paper
• Endothelial progenitor cell mobilization and platelet microparticle release are influenced by clopidogrel plasma levels in stable coronary artery disease.

  2012cites this paper
• Beneficial Effects of Statins on Endothelial Progenitor Cells

  2012cites this paper
• Endothelial Progenitor Cells and Left Ventricle Function in Patients With Acute Myocardial Infarction: Potential Therapeutic Considertions

  2012cites this paper
• Endothelial Progenitors and Repair of Cardiovascular Disease

  2012cites this paper
• Endothelial Progenitor Cells in the Treatment of Vascular Disease

  2012cites this paper
• The effects of early statin therapy on endothelial function in patients with acute myocardial infarction: A randomized study

  2012cites this paper
• Endothelial progenitor cells as therapeutic agents in the microcirculation: an update.

  2011cites this paper
• Predictors of circulating endothelial progenitor cell levels in patients without known coronary artery disease referred for multidetector computed tomography coronary angiography.

  2011influential citation
• Endothelin-1 levels predict endothelial progenitor cell mobilization after acute myocardial infarction.

  2011cites this paper
• Targeting stem cell niches and trafficking for cardiovascular therapy.

  2011influential citation
• Plasma Stromal cell-derived factor-1 bei Patienten mit koronarer Herzkrankheit: Einfluss von Klinik, kardiovaskulären Risikofaktoren und kardiovaskulärer Therapie

  2011cites this paper
• Effects of Preoperative Short Term Use of Atorvastatin on Endothelial Progenitor Cells after Coronary Surgery: A Randomized, Controlled Trial

  2011cites this paper
• Are endothelial progenitor cells mobilized by myocardial ischemia or myocardial necrosis? A cardiac magnetic resonance study.

  2011cites this paper
• Peripheral blood derived cell trafficking for cardiac regeneration.

  2010cites this paper
• FLUXO CORONARIANO, MICROEMBOLIA E OBSTRUÇÃO MICROVASCULAR APÓS TROMBOSE CORONARIANA AGUDA E REPERFUSÃO CORONÁRIA CORONARY FLOW, MICROVASCULAR OBSTRUCTION AND MICROEMBOLIZATION AFTER ACUTE CORONARY THROMBOSIS AND CORONARY REPERFUSION

  2010cites this paper
• Atorvastatin Increases the Number of Endothelial Progenitor Cells After Cardiac Surgery: A Randomized Control Study

  2010influential citation
• Bone marrow and circulating stem/progenitor cells for regenerative cardiovascular therapy.

  2010cites this paper
• Understanding the role of endothelial progenitor cells in percutaneous coronary intervention.

  2010cites this paper
• Atherosclerotic coronary artery disease

  2009cites this paper
• Role of endothelial progenitor cell mobilization after percutaneous angioplasty procedure.

  2009cites this paper
• Novel pathogenic insights in the primary prevention of cardiovascular disease.

  2009cites this paper
• Coronary microembolization: from bedside to bench and back to bedside.

  2009cites this paper
• Bibliography--editors' selection of current world literature.

  2009cites this paper
• Primary prevention of vascular events in patients with high levels of C-reactive protein: the JUPITER study

  2009cites this paper
• From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells.

  2008cites this paper
• Beneficial effects of statin treatment after myocardial infarction: Is progenitor cell mobilization the missing link?

  2008influential citation